Enfusion (ENFN)
NYSE:ENFN
US Market
Holding ENFN?
Track your performance easily

Enfusion (ENFN) Financial Statements

28 Followers

Enfusion Financial Overview

Enfusion's market cap is currently ―. The company's EPS TTM is $0.029; its P/E ratio is 285.42; Enfusion is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 49.45M$ 48.05M$ 46.49M$ 44.36M$ 39.61M
Gross Profit$ 33.49M$ 31.88M$ 30.86M$ 44.20M$ 28.51M
EBIT$ 9.04M$ 5.67M$ 2.13M$ 3.03M$ 1.19M
EBITDA$ 11.97M$ 8.41M$ 5.65M-$ 3.27M
Net Income Common Stockholders$ 1.83M$ -539.00K$ 638.00K$ 11.70M$ 629.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 34.45M$ 32.89M$ 35.60M$ 31.65M$ 27.77M
Total Assets$ 120.09M$ 110.96M$ 108.97M$ 101.74M$ 94.05M
Total Debt$ 18.00M$ 15.46M$ 15.44M$ 16.49M$ 12.81M
Net Debt$ -16.45M$ -17.43M$ -20.17M$ -15.16M$ -14.96M
Total Liabilities$ 30.68M$ 28.34M$ 31.49M$ 28.46M$ 21.81M
Stockholders Equity$ 64.27M$ 58.05M$ 53.67M$ 50.73M$ 48.09M
Cash Flow-
Free Cash Flow$ 6.31M$ 898.00K$ 9.51M-$ 3.80M
Operating Cash Flow$ 7.31M$ 1.53M$ 6.59M$ 12.11M$ 6.02M
Investing Cash Flow$ -5.71M$ -2.75M$ -2.29M$ -2.61M$ -2.22M
Financing Cash Flow$ -16.00K$ -1.37M$ -579.00K$ -5.31M$ -30.84M
Currency in USD

Enfusion Earnings and Revenue History

Enfusion Debt to Assets

Enfusion Cash Flow

Enfusion Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis